80
Participants
Start Date
March 31, 2014
Primary Completion Date
October 31, 2014
Study Completion Date
October 31, 2014
Placebo to BI 1026706 solution
Placebo to BI 1026706 solution
BI 1026706
BI 1026706
Placebo to BI 1026706 tablet
Placebo to BI 1026706 tablet
Celecoxib
Celecoxib capsule
1320.13.39001 Boehringer Ingelheim Investigational Site, Verona
Lead Sponsor
Boehringer Ingelheim
INDUSTRY